Bristol-Myers Squibb (BMY) Tops Q3 EPS by 30c, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Tops Q3 EPS by 30c, provides guidance

Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at Leerink Partners

November 4, 2024 6:20 AM EST

Leerink Partners analyst David Risinger raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $55.00 (from $53.00) while maintaining a Market Perform rating.

The analyst comments "Bottom line. We are increasing our PT from $53 (7.5x old 25E EPS of $7.06) to $55 (7.5x new 25E... More